Progyny
$31.99
146
+$0.06+0.19% 13:46 Today
Statistics
Day High
32.03
Day Low
31.65
52W High
32.36
52W Low
16.3
Volume
104,571
Avg. Volume
-
Mkt Cap
2.51B
P/E Ratio
39.81
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.1
0.18
0.26
0.33
Expected EPS
0.334745
Actual EPS
N/A
Financials
4.54%Profit Margin
Profitable1.29BRevenue
58.52MNet Income
Analyst Ratings
31.17Average Price Target
The highest estimate is 35.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 17%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PGNY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CVS Health
CVS
Mkt Cap132.89B
Unitedhealth Group
UNH
Mkt Cap385.62B
Cigna Group)
CI
Mkt Cap77.63B
Humana
HUM
Mkt Cap47.09B
Teladoc Health
TDOC
Mkt Cap1.68B
American Well
AMWL
Mkt Cap165.58M
Guardant Health
GH
Mkt Cap21.22B
Healthequity
HQY
Mkt Cap7.89B
About
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Show more...
CEO
Mr. David J. Schlanger J.D.
Employees
675
Country
United States
ISIN
US74340E1038
Listings
0 Comments
Share your thoughts
FAQ
What is Progyny stock price today?▼
The current price of PGNY is $31.99 USD — it has increased by +0.19% in the past 24 hours. Watch Progyny stock price performance more closely on the chart.
What is Progyny stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Progyny stocks are traded under the ticker PGNY.
Is Progyny stock price growing?▼
PGNY stock has risen by +0.09% compared to the previous week, the month change is a +22.74% rise, over the last year Progyny has showed a +45.5% increase.
What is Progyny market cap?▼
Today Progyny has the market capitalization of 2.51B
When is the next Progyny earnings date?▼
Progyny is going to release the next earnings report on July 30, 2026.
What were Progyny earnings last quarter?▼
PGNY earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.26 USD resulting in a +13.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Progyny revenue for the last year?▼
Progyny revenue for the last year amounts to 1.29B USD.
What is Progyny net income for the last year?▼
PGNY net income for the last year is 58.52M USD.
How many employees does Progyny have?▼
As of July 20, 2026, the company has 675 employees.
In which sector is Progyny located?▼
Progyny operates in the Health & Wellness sector.
When did Progyny complete a stock split?▼
Progyny has not had any recent stock splits.
Where is Progyny headquartered?▼
Progyny is headquartered in New York, United States.